Chen-chen Zhang
No. 241 Huai Hai Road
Huaihai, 200030, China
Huaihai, 200030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Is postoperative radiotherapy effective in patients with completely resected pathologic stage IIIA(N2) non-small cell lung cancer? High-risk populations should consider it.
Journal: Clinical and translational radiation oncology
Published: June 12, 2024
Combination of radiotherapy and PD-L1 blockade induces abscopal responses in EGFR-mutated lung cancer through activating CD8+ T cells.
Journal: Translational oncology
Published: February 25, 2024
A decision support framework for postoperative radiotherapy in patients with pathological N2 non-small cell lung cancer.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: March 01, 2022
Lymph Node Parameters Predict Adjuvant Chemoradiotherapy Efficacy and Disease-Free Survival in Pathologic N2 Non-Small Cell Lung Cancer.
Journal: Frontiers in oncology
Published: July 06, 2021
Prognostic index for estimating the survival benefit of postoperative radiotherapy in pathologic N2 non-small cell lung cancer: A real-world validation study.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: February 15, 2021
Radiotherapy for non-small cell lung cancer in the immunotherapy era: the opportunity and challenge-a narrative review.
Journal: Translational lung cancer research
Published: November 19, 2020
Analysis of Progression Patterns and Failure Sites of Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations Receiving First-line Treatment of Tyrosine Kinase Inhibitors.
Journal: Clinical lung cancer
Published: November 10, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026